Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia
Puedes acceder al artículo completo en este enlace: https://erj.ersjournals.com/content/59/3/2103036#abstract-2
Noticias relacionadas
Plasticity of Individual Lung Function States from Childhood to Adulthood
Recent evidence highlights the importance of optimal lung development during childhood for health throughout life. Objectives: To explore the plasticity of individual lung function states during childhood.
POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes
COPD is a complex and heterogeneous disease characterized by chronic airway inflammation. The latter may alter airway antimicrobial defense systems and therefore favor the colonization of the bronchial mucosa by potentially pathogenic microorganisms.
Más artículos
COVID19
- 20220307·Cruz, T., et al., SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae. ERJ Open Research, 2022. 8(1): p. 00706-2021
- 778991·Mona Bafadhel, Rosa Faner, Camille Taillé, Richard E.K. Russell, Tobias Welte, Peter J. Barnes and Alvar Agustí. Inhaled corticosteroids for the treatment of COVID-19
- 779199· Bartolome Celli et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision
- 779385·Alvar Agustí, Esther Pallisa, Domingo Escudero, Manel Escobar. Propuestas JANUS para la mejora de la experiencia de la persona atendida en consultas externas
- 779599·Alvar Agustí, Bernardino Alcázar, Julio Ancochea, Ciro Casanova, Bartolome Celli, Borja Cosio, José María Echave-Sustaeta, Alberto Fernandez Villar, Juan Luis Garcia Rivero, Cruz González, José Luis Iz. ANTES: Un año después en la EPOC
Recuerda que puedes acceder a varios enlaces a artículos en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imágenes obtenidas el 29/12/2022 de la aplicación Canva Pro.
